drugset / Trial / NCT00526916

PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28

NCT00526916

Phase 1 Completed 18 enrolled National Institute of Mental Health (NIMH)
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

The purpose of this protocol is to measure peripheral benzodiazepine receptors in the brain using positron emission tomography (PET) and compare the imaging results between patients and healthy people.

Timeline

Start
2007-09-04
Primary completion
Completion
2014-09-05

Drugs

EvaluationDrugModalityDoseRoute
Subject [C-11]PBR28 Diagnostic / imaging agent

Indications